Trypanosoma cruzi antigen detection in blood to assess treatment efficacy and cure in mice models of Chagas disease
IntroductionChagas disease (CD) is caused by the protozoan parasite Trypanosoma cruzi. Although endemic mainly in Latin America, CD has become a global public health problem due to migration of infected individuals to non-endemic regions. Despite progress made in drug development, preclinical assays...
Main Authors: | Fernanda Fortes de Araujo, Rana Nagarkatti, Ana Lia Mazzeti, Karolina Ribeiro Gonçalves, Lívia de Figueiredo Diniz, Isabela Campos do Vale, Olindo Assis Martins-Filho, Alain Debrabant, Maria Terezinha Bahia, Andréa Teixeira-Carvalho |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1340755/full |
Similar Items
-
Implications of genetic variability of Trypanosoma cruzi for the pathogenesis of Chagas disease Implicações da variabilidade genética do Trypanosoma cruzi na patogênese da doença de Chagas
by: Fernanda da Silva Manoel-Caetano, et al.
Published: (2007-10-01) -
Inositol metabolism in Trypanosoma cruzi: potential target for chemotherapy against Chagas' disease
by: MECIA M. OLIVEIRA, et al.
Published: (2000-09-01) -
Reaching for the Holy Grail: insights from infection/cure models on the prospects for vaccines for Trypanosoma cruzi infection
by: Juan Bustamante, et al.
Published: (2015-05-01) -
The Impact of the CTHRSSVVC Peptide Upon Experimental Models of Trypanosoma cruzi Infection
by: Gabriela Rodrigues Leite, et al.
Published: (2022-05-01) -
Morphobiological characterization of Trypanosoma cruzi Chagas, 1909 and its distinction from other Trypanosomes
by: Maria Auxiliadora de Sousa
Published: (1999-09-01)